Compare COCP & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCP | PMEC |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6M | 23.4M |
| IPO Year | 2011 | 2021 |
| Metric | COCP | PMEC |
|---|---|---|
| Price | $1.11 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 51.5K | ★ 101.8K |
| Earning Date | 11-13-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,712,091.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $0.31 |
| 52 Week High | $2.03 | $2.44 |
| Indicator | COCP | PMEC |
|---|---|---|
| Relative Strength Index (RSI) | 39.79 | 49.91 |
| Support Level | $0.99 | $0.50 |
| Resistance Level | $1.12 | $0.81 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 4.55 | 39.91 |
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Primech Holdings Ltd is a Singapore-based facilities services and AI robotics group with operations in Singapore and Hong Kong. Through its subsidiaries, the company provides integrated facilities management, cleaning and stewarding services to the public and private sectors, serving airports, educational institutions, healthcare facilities, commercial buildings and hospitality venues. It also develops HYTRON, an autonomous restroom-cleaning robot that uses AI perception and robotic manipulation. In addition, the company operates HomeHelpy, a digital platform for booking home services for consumers.